Study of Itraconazole in Patients With Advanced HIV Infection
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To demonstrate a dosage regimen for intravenous itraconazole that produces a plasma
concentration range comparable to that obtained after currently used oral dosages of
itraconazole oral solution; and to obtain preliminary safety data in patients with advanced
HIV disease.